|
Selected
publications
Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio
A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa
A, Fusco A, Santoro M. Cytoplasmic relocalization and
inhibition of the cyclin-dependent kinase inhibitor
p27(Kip1) by PKB/Akt-mediated phosphorylation in breast
cancer. Nat Med 2002;8:1136-44.
Carlomagno,
F, Vitagliano, D, Guida, T, Napolitano, M, Vecchio,
G, Fusco, A, Gazit, A, Levitzki A, Santoro M. The kinase
inhibitor PP1 blocks tumorigenesis induced by RET oncogenes.
Cancer Res 2002;62:1077-82.
Melillo
RM, Santoro M, Ong S-H, Billaud M, Fusco A, Schlessinger
J, Lax I. The docking protein FRS2 links RET and its
oncogenic forms with the RAS/MAPK cascade. Mol Cell
Biol 2001;21:4177-87.
Carlomagno
F, De Vita G, Berlingieri MT, de Franciscis V, Melillo
RM, Colantuoni V, Kraus MH, Di Fiore PP, Fusco A, Santoro
M. Molecular heterogeneity of RET loss of function in
Hirschsprung’s disease. EMBO J 1996;15:2717-25.
Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan
NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus
MH, di Fiore PP. Activation of RET as a dominant transforming
gene by germline mutations of MEN2A and MEN2B. Science
1995;267:381-3.
|